Robert E. Dudley

Biography

 Robert E. Dudley, Ph.D., has served as our Chief Executive Officer, President and Chairman of our board of directors since Clarus's inception in February 2004. Prior to that, from 2001 to 2003, he served as President, Chief Executive Officer, and Director of Anagen Therapeutics, Inc., a private biopharmaceutical company affiliated with the University of Chicago. He served as President, Chief Executive Officer, and Director of Unimed Pharmaceuticals, Inc. from 1999 to 2001 during which time Unimed received FDA approval for and launched AndroGel (which he co-invented).  From 1994 to 2001, Dr. Dudley held several senior level executive positions at Unimed Pharmaceuticals, Inc., a public company acquired by Solvay Pharmaceuticals in 1999.  Dr. Dudley has over 25 years of experience in the field of testosterone replacement therapy, has published numerous articles in peer-reviewed medical journals, and is an inventor on several testosterone-related patents – including those patents that cover Clarus' oral TU formulations. 

Research Interest

Dr. Dudley received his B.S. in Biology from Pepperdine University, Seaver College, his M.S. in Biology from University of New Mexico, and his Ph.D., with honors, in Pharmacology and Toxicology from the University of Kansas School of Medicine.  Dr. Dudley is also a board-certified toxicologist.